Medpace Holdings, Inc. (MEDP) /
The cash flow of Medpace Holdings, Inc. over the past 10 years
Chart Medpace Holdings, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Medpace Holdings, Inc.'s operating cash flow was $713.22M and its capital expenditures $31.36M, leaving free cash flow of $681.87M. Free cash flow was above zero in all 10 years shown. It ranged from $78.19M in fiscal 2016 to $681.87M in fiscal 2025. Capital expenditures were highest in fiscal 2022, at $36.88M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $713.22M | $31.36M | $681.87M |
| 2024ended Dec 31, 2024 | $608.82M | $36.55M | $572.27M |
| 2023ended Dec 31, 2023 | $433.37M | $36.65M | $396.73M |
| 2022ended Dec 31, 2022 | $388.05M | $36.88M | $351.17M |
| 2021ended Dec 31, 2021 | $263.33M | $28.27M | $235.06M |
| 2020ended Dec 31, 2020 | $258.68M | $31.34M | $227.34M |
| 2019ended Dec 31, 2019 | $201.87M | $17.91M | $183.96M |
| 2018ended Dec 31, 2018 | $156.58M | $16.02M | $140.56M |
| 2017ended Dec 31, 2017 | $97.39M | $11.72M | $85.66M |
| 2016ended Dec 31, 2016 | $91.73M | $13.54M | $78.19M |
Fiscal years as Medpace Holdings, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Medpace Holdings, Inc.
- The revenue of Medpace Holdings, Inc.
- The profitability of Medpace Holdings, Inc.
- The debt of Medpace Holdings, Inc.
- All of Medpace Holdings, Inc.'s financials, charted
Companies of a similar size
- ZBHZIMMER BIOMET HOLDINGS, INC.
- FTVFortive Corporation
- TSEMTOWER SEMICONDUCTOR LTD.
- DTDynatrace, Inc.
- TOSTToast, Inc.
Not investment advice. This page shows what Medpace Holdings, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.